01 / DESIGN
What was studied?
Biophysical membrane assays and neuroblastoma-cell experiments examined alpha-synuclein binding, aggregation and mitochondrial stress.
02 / FINDINGS
What did the researchers report?
SS-31 altered membrane binding and aggregation patterns and improved selected cell-viability and respiration measurements after exposure to oligomers.
03 / LIMITS
How should it be interpreted?
Artificial membranes and cell lines simplify a complex disease process. The work does not establish prevention or treatment of Parkinson's disease in humans.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.